COLOMATE challenge to overcome resistance in metastatic colorectal cancer

被引：0
|
作者：
Yoshino, Takayuki [1 ]
机构：
[1] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan
来源：
ONCOLOGY-NEW YORK | 2021年 / 35卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：656 / 657
页数：2
相关论文
共 50 条
  • [1] Genomic profiling to overcome resistance to molecularly targeted therapies in metastatic colorectal cancer
    Strickler, John H.
    CANCER SCIENCE, 2023, 114 : 1522 - 1522
  • [2] The challenge of Metastatic colorectal cancer
    Una Cidon, Esther
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2010, 4 : 55 - 60
  • [3] Recent and Future Strategies to Overcome Resistance to Targeted Therapies and Immunotherapies in Metastatic Colorectal Cancer
    Dazio, Giulia
    Epistolio, Samantha
    Frattini, Milo
    Saletti, Piercarlo
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (24)
  • [4] Sorafenib overcome irinotecan resistance in colorectal cancer
    Mazard, Thibault
    Causse, Annick
    Leconet, Wilhem
    Assenat, Eric
    Ychou, Marc
    Del Rio, Maguy
    Martineau, Pierre
    Robert, Bruno
    Gongora, Celine
    CANCER RESEARCH, 2012, 72
  • [5] BEVACIZUMAB IN METASTATIC COLORECTAL CANCER: MOROCCAN CHALLENGE
    Mouzount, H.
    Allam, W.
    Errihani, H.
    ANNALS OF ONCOLOGY, 2009, 20 : 73 - 73
  • [6] Strategies to overcome resistance to epidermal growth factor receptor monoclonal antibody therapy in metastatic colorectal cancer
    Jeong, Woo-Jeong
    Cha, Pu-Hyeon
    Choi, Kang-Yell
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (29) : 9862 - 9871
  • [7] Strategies to overcome resistance to epidermal growth factor receptor monoclonal antibody therapy in metastatic colorectal cancer
    Woo-Jeong Jeong
    Pu-Hyeon Cha
    Kang-Yell Choi
    World Journal of Gastroenterology, 2014, (29) : 9862 - 9871
  • [8] Overcome Multidrug Resistance in Colorectal Cancer by Natural Compounds
    Li, Yanxi
    Liu, Zhexian
    Guo, Xingqi
    Ma, Siping
    SCIENCE OF ADVANCED MATERIALS, 2020, 12 (07) : 933 - 949
  • [9] Supermolecular drug challenge to overcome drug resistance in cancer cells
    Onishi, Yasuhiko
    Eshita, Yuki
    Ji, Rui-Cheng
    Kobayashi, Takashi
    Onishi, Masayasu
    Mizuno, Masaaki
    Yoshida, Jun
    Kubota, Naoji
    DRUG DISCOVERY TODAY, 2018, 23 (08) : 1556 - 1563
  • [10] Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancer
    Amin, Manik
    Desai, Monica
    Trinkaus, Kathryn
    Brown, Amberly
    Wang-Gillam, Andrea
    Tan, Benjamin
    Picus, Joel
    Sorscher, Steven
    Highkin, Maureen
    Lears, Kim
    Lockhart, Albert C.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 10 (03) : 412 - 420
12345